Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > QDC announced the appointment of George Dunbar

April 20th, 2004

QDC announced the appointment of George Dunbar

Abstract:
Dunbar’s experience includes more than 25 years as CEO, director, and senior manager with many private and public bioscience companies. Most recently he worked with investors as CEO to sell Targesome, an early-stage targeted drug delivery start-up. Prior to Targesome, Dunbar was CEO of Epic Therapeutics, a controlled release formulation company sold to Baxter Healthcare in 2002.

Source:
NN

Bookmark:

Related News Press

Appointments/Promotions/New hires/Resignations/Deaths

Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013

SEMATECH Names William R. Rozich Chairman of the Board June 13th, 2013

David Neuschuler Joins RASIRC to Manage Engineering June 3rd, 2013

Asylum Research Announces Ben Ohler as AFM Business Manager May 29th, 2013